Transcriptional arrest triggers ubiquitylation of RNA polymerase II (RNAPII). We mapped the yeast RNAPII ubiquitylation sites and found that they play an important role in elongation and the DNA-damage response. One site lies in a protein domain that is unordered in free RNAPII, but ordered in the elongating form, helping explain the preferential ubiquitylation of this form. The other site is >125 Å ngstroms away, yet mutation of either site affects ubiquitylation of the other, in vitro and in vivo. The basis for this remarkable coupling was uncovered: an Rsp5 (E3) dimer assembled on the RNAPII C-terminal domain (CTD). The ubiquitylation sites bind Ubc5 (E2), which in turn binds Rsp5 to allow modification. Evidence for folding of the CTD compatible with this mechanism of communication between distant sites is provided. These data reveal the specificity and mechanism of RNAPII ubiquitylation and demonstrate that E2s can play a crucial role in substrate recognition.
INTRODUCTION
Protein ubiquitylation has emerged as a crucial and common conduit for the regulation of cellular processes. Protein monoubiquitylation serves to alter the activity of the target protein or to tag it for interaction with other factors. In contrast, multiubiquitylation typically leads to degradation of the target protein by the proteasome (Varshavsky, 1997; Pickart, 2001) . Ubiquitylation requires the cooperation of three enzymes: E1 (ubiquitin-activating protein), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin ligase) (Pickart, 2001) . There is only one E1 in eukaryotic cells, but several E2s and innumerable E3s. While the E1 merely activates ubiquitin, the E2 and the E3 form a transient complex, which recognizes and ubiquitylates the protein substrate. E2/E3 complexes of two main types exist (Ardley and Robinson, 2005) : those where the E3 recognizes the substrate to allow ubiquitin transfer directly from the E2 (E3s of the RING-finger/U-box families) and those where the E3 both recognizes the substrate and ubiquitylates it. Here, ubiquitin transfer is from the E2 to the E3 and then to the substrate (homologous to the E6-AP carboxyl terminus [HECT] domain E3s). Interestingly, although several examples of the effects and importance of ubiquitylation have been reported, key questions about the mechanism of protein ubiquitylation remain unanswered. For example, the manner in which recognition of the substrate and its site-specific ubiquitylation are connected is poorly understood, and detailed examples of the reaction mechanism of different E2-E3 pairs are relatively few. It is generally believed that only the E3 recognizes and positions the substrate for ubiquitylation. The substrate binding sites of E3s are, however, typically quite far from the site of actual ubiquitylation (the E3 active site). Moreover, in the few cases where structural data on an E2-E3 complex is available, the active site of the E2 and the active site of the HECT E3 are also far apart (Huang et al., 1999) , necessitating substantial structural rearrangements to occur during substrate recognition and catalysis (Verdecia et al., 2003) . A better understanding of the cooperation between E2 and E3 during catalysis is crucial to understand protein ubiquitylation.
One interesting substrate for protein ubiquitylation is RNAPII, which transcribes all protein-encoding genes in eukaryotes (Boeger et al., 2005) . Polyubiquitylation and degradation of RNAPII was first thought to occur specifically in response to DNA damage (Bregman et al., 1996; Ratner et al., 1998; Beaudenon et al., 1999) , but recent experiments have shown that RNAPII arrested during transcript elongation is generally prone to ubiquitylation and degradation (Somesh et al., 2005) . Thus, it has been suggested that degradation of RNAPII is a ''last resort,'' used to clear active genes of persistently arrested RNAPII elongation complexes (Woudstra et al., 2002; Svejstrup, 2003; Somesh et al., 2005) . We recently reconstituted RNAPII ubiquitylation in vitro with highly purified yeast ubiquitylation factors and showed that the elongating RNAPII form is a much better substrate than the free form (Somesh et al., 2005) . However, the explanation for this substrate discrimination by highly purified proteins was not apparent. The HECT E3 among the ubiquitylation factors, Rsp5, binds RNAPII via the flexible C-terminal repeat domain (CTD) of the Rpb1 subunit (Huibregtse et al., 1997) . Interestingly, although the CTD is absolutely required for RNAPII ubiquitylation, Rsp5-mediated modification occurs in the main body of the Rpb1 subunit (Peng et al., 2003; Somesh et al., 2005) . The importance for transcription and the DNA-damage response of site-specific RNAPII ubiquitylation has not been addressed. We have now mapped sites of RNAII ubiquitylation to facilitate an understanding of the role of such modification in vivo, with the additional goal of understanding the mechanism of RNAPII ubiquitylation. We discovered two distinct Rpb1 ubiquitylation sites, K330 and K695. Mutation of these sites has important functional consequences for transcript elongation and the DNA-damage response. Remarkably, although these sites are far apart (more than 125 Å ngstroms), their modification is coordinated in vitro as well as in vivo, suggesting that an E2/E3/RNAPII complex is assembled that depends on not only the RNAPII CTD but also on the Rpb1 ubiquitylation sites themselves. We have indeed identified such a complex, revealing the mechanistic basis for RNAPII ubiquitylation and also the role of the CTD. We further show that, surprisingly, it is the E2 (Ubc5) that recognizes the sites of modification.
RESULTS
In order to map sites of RNAPII ubiquitylation, yeast RNAPII was ubiquitylated in vitro by highly purified ubiquitylation factors (Uba1, Ubc5, and Rsp5) and subjected to mass spectrometric analysis. We recently reported that this approach identified an ubiquitylated peptide containing Rpb1 K695 (Somesh et al., 2005) , which was also independently identified as a target of RNAPII ubiquitylation in vivo (Peng et al., 2003) . Our further analysis uncovered another peptide, in which GG from the C terminus of ubiquitin was linked to ''ARLKGKEGR'' of Rpb1. This indicated that either K330 or K332 is also a target of ubiquitylation ( Figure 1A ).
The RNAPII Ubiquitylation Sites Mapped In Vitro Are Also Targeted In Vivo
The biological relevance of the mapped ubiquitylation sites was first investigated by site-directed mutagenesis and analysis in vivo. In our initial approach, K330 and K332 were comutated, but subsequent experiments indicated that the actual site of ubiquitylation is K330 (or at least that if ubiquitylation also occurs at K332, it has no functional consequence [ Figure S1 ]). Independent mutation of lysine 330, or lysine 695, to arginine did not result in a growth phenotype under normal conditions. In contrast, concomitant mutation of both sites was lethal ( Figure 1B) .
In order to investigate the role of the RNAPII ubiquitylation sites in transcript elongation in vivo, the effect of the Cramer et al. [2001] ) is shown. The following abbreviations are used: S.c., Saccharomyces cerevisiae; H.s., Homo sapiens. Arrows indicate potential ubiquitylation sites. (B) Phenotypic consequences of mutating K330 and/or K695 to arginine. Cells carrying (URA3 CEN) plasmid-borne wt RBP1 were transformed with (TRP1 CEN) plasmids expressing wt or mutant Rpb1. Dilution series were grown on yeast minimal medium (SD), or 5-fluoroorotic acid (5-FOA), respectively, for 2-4 days at 30 C to evict the URA3 plasmid.
(C) Sensitivity of Rpb1 ubiquitylation-site mutants to 6-azauracil (6-AU), compared to that of cells lacking DST1 (encoding TFIIS).
(D) Viability of cells expressing the Rpb1 ubiquitylation-site mutants was tested as described in (B), but in a dst1 strain.
(E) Rpb1 ubiquitylation in response to transcriptional arrest in wt, K330R, and K695R cells. The upper panel shows a western blot of RNAPII immunoprecipitations from the indicated cell types treated (+) or not treated (À) with 6-azauracil (6-AU), probed with anti-ubiquitin antibodies. The lower panel shows Ponceau S stain of the membrane used for the western blot. Size markers are indicated on the left and the identity of protein bands on the right. elongation inhibitor 6-azauracil (6-AU) on the growth of the single mutants (K330R and K695R) was tested. 6-AU causes a decrease in cellular UTP/GTP levels and thus increases transcriptional arrest (Mason and Struhl [2005] and references therein). The growth rate of both mutants was significantly affected by 6-AU, suggesting a role for the residues in transcript elongation in vivo ( Figure 1C) . Moreover, mutation of K330 (but not K695) was lethal in cells lacking the general elongation factor, TFIIS (encoded by DST1) ( Figure 1D ). Together, these data suggest a role for the ubiquitylatable lysines in transcript elongation.
We next investigated the roles of K330 and K695 in RNAPII ubiquitylation in vivo. Following treatment with 6-AU to induce RNAPII arrest and Rpb1 ubiquitylation, the polymerase was immunopurified and subjected to western blotting, using antiubiquitin antibodies ( Figure 1E ). As expected (Somesh et al., 2005) , wild-type (wt) RNAPII became polyubiquitylated under these conditions, but little ubiquitylation was detected with RNAPII from K695R cells, and even less with RNAPII from K330R cells, indicating that the sites are indeed targets for arrest-induced RNAPII ubiquitylation.
The RNAPII Ubiquitylation Sites Play a Role in the Damage Response RNAPII is ubiquitylated and degraded in response to ultraviolet (UV) irradiation, and we previously proposed that this represents an alternative to removal of DNA damage by transcription-coupled repair (TCR) (Woudstra et al., 2002; Svejstrup, 2003) . Similar to cells lacking RAD26 (encoding the yeast TCR factor homologous to human Cockayne syndrome B [van Gool et al., 1994] ), cells carrying mutations in the RNAPII ubiquitylation sites were not UV sensitive. In agreement with the proposed model, however, cells lacking both RAD26 and one of the RNAPII ubiquitylation sites (especially K330) were highly UV sensitive (Figure 2A) . Moreover, RNAPII ubiquitylation in response to UV irradiation was dramatically reduced in the K695R mutant ( Figure 2B , compare lanes 2 and 6). In K330R, ubiquitylation was almost undetectable, with only a very low level of modification detected in some experiments ( Figure 2B , compare lanes 2 and 4; data not shown).
RNAPII ubiquitylation was previously shown to result in degradation by the proteasome (Ratner et al., 1998; Beaudenon et al., 1999) . Interestingly, though RNAPII ubiquitylation was reduced in K695R, no reduction in the level of this RNAPII mutant was observed upon UV irradiation. In contrast, the level of the K330R mutant was dramatically reduced ( Figure 2C , compare Rpb1 levels in lanes 2 and 3, 7 and 8, and 12 and 13). These data correlate with the UV sensitivity of the mutants observed in the rad26 background and support the idea that cell viability during DNA damage in genes relies on an ability to either perform TCR or degrade RNAPII efficiently so that repair can take place by other mechanisms (Svejstrup, 2003) .
The in vivo observations were mirrored by in vitro experiments performed with recombinant ubiquitylation factors and highly purified wt or mutant RNAPII ( Figure 2D ). Only low levels of ubiquitylation of the mutant polymerases was detected under conditions that yielded efficient polyubiquitylation of wt RNAPII, and even monoubiquitylation (D) RNAPII ubiquitylation was reconstituted in vitro using highly purified factors (Uba1, Ubc5, and Rsp5 [Somesh et al., 2005] ) in combination with his-tagged ubiquitin (left panel) or his-tagged ubiquitin lacking lysines (mono-ubiquitylation) (right panel), respectively. Ubiquitylation products were separated by SDS-PAGE and uncovered by probing Western blots with anti-hexahistidine antibodies (Somesh et al., 2005) .
was dramatically reduced ( Figure 2D , left and right panel; data not shown). Taken together, the data above strongly suggest that Rpb1-K695 and -K330 are indeed relevant and important RNAPII ubiquitylation sites. Moreover, the finding that mutation of either site is sufficient to dramatically reduce overall RNAPII ubiquitylation both in vivo and in vitro was intriguing, as it suggests that modification of the two sites is somehow interdependent.
Placement of the Ubiquitylation Sites in the RNAPII Structure
The location of the ubiquitylation sites in the RNAPII crystal structure ( Figure 7A ; see also Figure S6 ) led to several conclusions. First, K330 is situated in the so-called switch 2 domain, which is unordered in free RNAPII, but highly ordered in the elongating form of the enzyme (Gnatt et al., 2001 ). This location may explain the strong preference of ubiquitylation for the elongating form of RNAPII compared to the free form, even in vitro (Somesh et al., 2005) : a major target site for the ubiquitylation machinery adopts a conformation in this form of the enzyme that allows efficient modification. Secondly, the sites are located far apart (about 125 Å ngstroms), on opposite faces of RNAPII and far away from the (exit point of the) CTD ( Figure 7A ), which is also required for ubiquitylation.
The E3, Rsp5, but Not the E2, Ubc5, Requires the CTD for Association with RNAPII We investigated the interdependence of the two distant ubiquitylation sites and their spatial relationship with the CTD with the use of our defined ubiquitylation system for studies in vitro. We surmised that the site interdependence would best be explained if establishment of a functional ubiquitylation complex on RNAPII requires binding of the E2 and/or the E3 to the regions around the sites. In this case, if one of the sites were absent, correct RNAPII binding by the ubiquitylation factors might be perturbed and only little ubiquitylation take place. As mentioned, the CTD of RNAPII is required for ubiquitylation (Somesh et al., 2005) , and the E3, Rsp5, is known to bind the RNAPII CTD directly (Huibregtse et al., 1997) . Thus, assembly of the ubiquitylation complex might involve interactions with both the CTD and the region around the ubiquitylation sites.
To first investigate whether Rsp5 or Ubc5 require the CTD for interaction with RNAPII, we used immobilized RNAPII-HA, or immobilized RNAPII lacking the CTD (RNAPIIDCTD-HA; Li and Kornberg [1994] ; Somesh et al. [2005] ) and incubated them with either recombinant GST-Rsp5 or GST-Ubc5 (Figure 3 ). GST-Rsp5 bound well to immobilized RNAPII containing the CTD but failed to interact with CTD-less RNAPII ( Figure 3A) . Likewise, CTD-containing, but not CTD-less, RNAPII bound immobilized GST-Rsp5 ( Figure S2 ). In contrast, GST-Ubc5 bound to both RNAPII and RNAPIIDCTD ( Figure 3B ).
Our previous data showed that RNAPII ubiquitylation is inhibited by serine 5 phosphorylation both in vivo and in vitro (Somesh et al., 2005) . Rsp5-RNAPII binding experiments with purified proteins uncovered the likely mechanistic basis for this, as Rsp5 failed to bind serine 5-phosphorylated RNAPII ( Figure 3C , compare lanes 2 and 4).
Ubc5
Binds to the RNAPII Ubiquitylation Sites As Ubc5 binds RNAPII in a CTD-independent manner, we investigated binding of this protein to RNAPII carrying point mutations in the Rpb1 ubiquitylation sites. GSTUbc5 was immobilized on glutathione beads (with GST alone as control), and incubated with wt or mutated forms of RNAPII ( Figure 3D ). Strikingly, whereas wt RNAPII bound efficiently to beads containing Ubc5, binding of K695R-RNAPII was slightly, but reproducibly, reduced, and binding of RNAPII-K330R was dramatically reduced (compare lanes 5-7, 11-13, and 17-19) .
To investigate if residual (weak) binding of Ubc5 to K695 still occurred in the RNAPII-K330R mutant and if a detectable reduction in binding could be observed in the RNAPII-K695R mutant, wt and mutant RNAPIIs were now immobilized via their CTD, and incubated with GST-Ubc5 ( Figure 3E ). Using this experimental approach, we consistently observed reduced binding of Ubc5 to RNAPII-K695R ( Figure 3E , compare lanes 10-12 with 4-6). It was also clear that RNAPII-K330R retains some capacity for binding Ubc5 ( Figure 3E , compare lanes 7-9 with 4-6 and 1-3 [control]).
As expected, point mutation of the Rpb1 ubiquitylation sites had no effect on the RNAPII binding of Rsp5 (data not shown).
Together, these data indicate that Ubc5, but not Rsp5, recognizes and binds the actual sites of modification in RNAPII.
Ubiquitylation of RNAPII Requires the Active Sites of Both Ubc5 and Rsp5
The finding that Ubc5 rather than Rsp5 recognizes the RNAPII ubiquitylation sites was surprising because E2s are generally not believed to be involved in target recognition. In ubiquitylation by HECT family ubiquitin ligases (to which Rsp5 belongs), ubiquitin is transferred from the active site of the E2 to that of the E3, and then to the target. It was therefore relevant to test whether ubiquitin transfer might occur directly from Ubc5 to the polymerase, rather than via Rsp5's active site. If Rsp5 were merely serving a structural role, it might thus be expected that a point mutation in its active site would have no effect on ubiquitylation. As can be seen in Figure 3F , however, the active sites of Rsp5 and Ubc5 were both absolutely required for RNAPII ubiquitylation. This suggests that an Ubc5-Rsp5-substrate complex is established at the ubiquitylation sites, in which ubiquitin is transferred from E2 to E3 to substrate, as is normally observed with HECT E3 ligases.
Evidence for a Multimeric E2/E3 Complex
The interdependence of the ubiquitylation sites, the fact that Rsp5 binds RNAPII via the highly repeated C-terminal domain (CTD), and the finding above that point mutation of either ubiquitylation site affects Ubc5 binding could be explained if modification occurs in a multimeric E2/E3 complex, capable of accessing two sites. This prompted us to investigate how many molecules of Rsp5 and Ubc5 bind to RNAPII (Figure 4 ). This was done by two approaches. First, we titrated increasing amounts of Rsp5 into an RNAPII binding reaction. Scanning of the resulting Coomassie-stained gels suggested that RNAPII binding reached a plateau at two molecules of Rsp5 ( Figure S3 ). (C) Immobilized GST, or GST-Rsp5, was incubated with RNAPII (RNAPIIA), or serine 5-phosphorylated RNAPII (RNAPII0-Ser5), respectively. Proteins were resolved by 10% SDS-PAGE, and western blot of bound Rpb1 was probed with 4H8 (lanes 1 and 2) and anti-Ser5 (H14) (lanes 3 and 4) antibody, respectively. (D) Immobilized GST (lanes 2-4, 8-10, and 14-16) or GST-Ubc5 (lanes 5-7, 11-13, and 17-19) was incubated with varying amounts (0.3, 0.6, and 0.9 mg) of the different forms of RNAPII indicated on top. Shown in the upper panel is a western blot of bound protein, probed with anti-Rpb1 (4H8) antibodies. Shown in the lower panel is a Ponceau S stain of the membrane showing GST and GST-Ubc5 used in the different experiments. (E) Immobilized RNAPII ($0.3 mg of version indicated on top) was incubated with varying amounts (0.3, 0.6, and 1 mg) of GST-Ubc5. Shown in the upper panel is a western blot of bound protein, probed with anti-GST antibodies. Shown in the lower panel is a Ponceau S stain of the membrane showing immobilized RNAPII. Please note that less stringent conditions were used in these experiments than in (D). (F) RNAPII ubiquitylation in vitro using wt and point-mutated active site versions of Rsp5 (left panel) and Ubc5 (right panel), respectively.
In a second approach, increasing amounts of untagged Rsp5 were titrated into a binding reaction containing a constant amount of GST-Rsp5 and RNAPII. Associated proteins were then isolated on glutathione-sepharose beads via the tag on GST-Rsp5 and the beads examined for the presence of untagged Rsp5 ( Figure 4A ). Untagged Rsp5 only associated with GST-Rsp5 in the presence of RNAPII ( Figure 4A , compare lane 1 with lanes 2-5), in agreement with the notion that Rsp5 otherwise behaves as a monomeric protein (data not shown) and indicating that the dimerization sometimes observed with GSTtagged proteins was not a problem in these experiments. Significantly, upon addition of increasing amounts of Rsp5 protein, the level of bound, untagged Rsp5 reached a plateau at a level similar to that of GST-Rsp5, as expected if two molecules of Rsp5 concomitantly bind RNAPII.
The same experimental approach was taken to investigate if more than one copy of Ubc5 bind RNAPII ( Figure 4B and data not shown). Untagged Ubc5 bound immobilized GST-Ubc5 in an RNAPII-dependent manner, and the amounts of protein bound indicated that at least two Ubc5 molecules bind RNAPII ( Figure 4B , compare GSTUbc5 and Ubc5 in lanes 4 and 5).
The Role of the CTD in the Establishment of a Functional Ubiquitylation Complex
The above experiments support a model in which Ubc5 molecules bind RNAPII at the sites of ubiquitylation and then allow the recruitment of two copies of CTD bound Rsp5 to trigger site-specific ubiquitylation. The CTD and its linker are presumed to be highly flexible and can, in an extended state, span hundreds of Å ngstroms from base to tip. The CTD might, however, alternatively be ordered in a discrete fold that makes the effective length much shorter (reviewed by Meinhart et al. [2005] ). Indeed, yeast cells with 10-12 CTD repeats (rather than the normal 26) are only conditionally viable, and a minimum of 10 repeats are required for viability (Nonet et al., 1987) . The distance from the last ordered residue at the base of the CTD linker across the surface of RNAPII to Rpb1 lysine 695 is more than 175 Å ngstroms (refer to Figure 7A ). In light of the above results it was therefore interesting to investigate if a shorter CTD is capable of supporting RNAPII ubiquitylation. RNAPII with 12 CTD repeats (Nonet et al., 1987) was therefore purified ( Figure 5A ) and tested in the ubiquitylation assay. Strikingly, ubiquitylation of RNAPII-12 was dramatically reduced ( Figure 5B ). Binding experiments showed that RNAPII-12 could still associate with Rsp5, although clearly less efficiently ( Figure 5C and data not shown), opening the possibility that the binding of Rsp5 to RNAPII is cooperative. These data indicate a CTD length requirement for a productive RNAPII ubiquitylation complex to form.
Formation of a Functional Ubiquitylation Complex Requires Ubc5 Binding to the Region around the Ubiquitylation Sites
The results above support the idea that two molecules of Rsp5 associate with the CTD to organize a complex capable of ubiquitylating RNAPII via interaction with Ubc5 molecules bound to the regions surrounding the sites. To further experimentally explore this model, we first investigated whether Ubc5 and Rsp5 directly interact. This was indeed the case ( Figures 6A and S4) .
We next performed gel migration-retardation experiments with preformed RNAPII elongation complexes (Figures 6B and 6C) . Addition of the Ubc5 protein alone did not radically affect the migration of the RNAPII/DNA/ RNA ternary complex ( Figures 6B [lanes 1 and 2] and 6C [labeled ''tern.'']). Addition of Rsp5, however, retarded migration dramatically, leading to an extended smear of more slowly migrating RNAPII elongation complexes (Figures containing Ubc5 and Rsp5 is unknown but might be due to their size difference (16 kDa versus 92 kDa) or, more likely, that Ubc5 binds the body of the polymerase, while Rsp5 binds the flexible CTD.
Significantly, addition of Ubc5 to the RNAPII-Rsp5 complex increased, rather than further decreased, complex mobility, leading to a much better defined band in the gel. (Figure 6B , lane 4 and labeled with asterisk). Antibody super-shift experiments showed that both Rsp5 and Ubc5 were indeed present in this complex ( Figure 6B , compare lanes 5 and 6 with lane 4). These data support the idea that the Rsp5-associated, flexible CTD exists in a number of different structural conformations but that, as a consequence of Ubc5-Rsp5 association, it becomes ordered across the surface of RNAPII. In agreement with the flexible CTD contributing significantly to the gel mobility of RNAPII elongation complexes, RNAPII-12 and RNAPIIDCTD indeed migrated faster than wt complexes ( Figure 6B , compare lanes 7, 9, and 11). As expected, only the mobility of the polymerase complexes lacking the CTD remained unchanged upon addition of Rsp5 ( Figure 6B, lane 12) , showing that the Rsp5-mediated mobility shift of wt (lane 8) and CTD-12 (lane 10) RNAPII complexes was due to Rsp5-CTD interactions.
The experiments of Figure 3D showed that RNAPII with mutated ubiquitylation sites (in particular K330R) is unable to associate with immobilized Ubc5 in a stable manner. If Ubc5 orders the Rsp5-CTD complex on the surface of RNAPII, then this might not occur with mutated ubiquitylation sites. The mobility shift caused by Ubc5/Rsp5 addition was therefore investigated using the RNAPII ubiquitylation-site mutants ( Figure 6C ). Under conditions that led to a clear increase in the mobility of wt RNAPII-Rsp5 complexes upon Ubc5 addition, little or no mobility shift of the K330R mutant complex was observed ( Figure 6C , compare lanes 3 and 4 with lanes 7 and 8). Mobility of the RNAPII-Rsp5 complex carrying the Rpb1-K695R mutation was slightly affected by Ubc5 addition, but not to the extent observed with wt RNAPII ( Figure 6C , compare lanes 3 and 4 with lanes 11 and 12; relevant complex designated on right-hand side by asterisk). These results strongly support the idea that Ubc5 binds the Rpb1 ubiquitylation sites and thereby positions the (CTD-associated) Rsp5 molecules correctly, so that site-specific ubiquitylation can take place.
DISCUSSION
The results reported here provide novel information on several levels. First, two ubiquitylation sites in the largest subunit of yeast RNAPII, K330, and K695, have been identified. Mutation of these sites gives rise to elongation phenotypes and defects in the DNA-damage response, and RNAPII ubiquitylation in vivo and in vitro is perturbed. Secondly, the data detail the molecular mechanism underlying RNAPII ubiquitylation by Rsp5 and Ubc5. Two copies of each bind RNAPII to couple distant ubiquitylation events. Thirdly, our data challenge the generally accepted view that E3s alone recognize the protein substrates. The E2, Ubc5, binds directly to RNAPII, and this binding is perturbed if one of the ubiquitylation sites is mutated. Finally, the results are informative about the structure and function of the RNAPII CTD. Together, the data give unprecedented insight into the biochemical mechanism underlying RNAPII ubiquitylation and provide a new paradigm for understanding protein ubiquitylation by HECT ubiquitin ligases.
RNAPII Ubiquitylation Sites
The data presented here show that the Rpb1 ubiquitylation sites mapped in vitro using pure ubiquitylation factors are also important for transcriptional elongation, the DNAdamage response, and RNAPII ubiquitylation in response to transcriptional arrest in vivo. For example, mutation of K330 in combination with mutation of Rad26 (required for TCR) gives rise to a dramatic increase in yeast UV sensitivity. Such a dramatic increase is not seen with the K695 mutation (which, in contrast to K330R, has little effect on RNAPII degradation). We previously suggested that ubiquitylation/degradation of RNAPII represents an important alternative to DNA repair by TCR (Woudstra et al., 2002; Svejstrup, 2003) , so these results provide strong evidence in support for this model. (B) Ubiquitylation of RNAPII-12. For technical reasons, monoubiquitylation (using ubiquitin lacking lysines) was compared in this experiment, but polyubiquitylation was also dramatically decreased (data not shown). (C) An excess of GST-Rsp5 was incubated with similar amounts of RNAPII and RNAPII-12 (see A), respectively, and resin-associated proteins resolved on SDS-PAGE after washing. A Coomassie-stained gel is shown.
The results from a combination of in vivo and in vitro experiments suggest that Rpb1 ubiquitylation is likely have evolved as more than simply a mechanism to allow degradation of the polymerase. Indeed, given that Rsp5 binds RNAPII via the CTD (Huibregtse et al., 1997; Somesh et al., 2005) , it might have been expected that any one of the numerous surface-exposed lysines in Rpb1/RNAPII would be a potential target and that there would simply be ''preferred'' sites for ubiquitylation on the path to polymerase degradation. However, this is clearly not the case. Very specific sites are targeted, and without these sites, little RNAPII ubiquitylation takes place, with consequences for transcription and the DNA-damage response. This could indicate that the actual location of the ubiquitylation sites is of functional importance.
Interestingly, whereas the single K330R and K695R mutations did not give rise to discernable growth phenotypes on rich media, mutation of both sites was lethal. In view of the fact that K330R mutation in itself is sufficient to result in significant abrogation of RNAPII ubiquitylation and degradation in vivo (but has no growth phenotype), this supports the idea that the sites may perform both overlapping, and nonoverlapping, roles in RNAPII biology. It is additionally possible, however, that a low level of ubiquitylation/ degradation through K695 still persists in the K330R mutant in vivo. This might be sufficient for survival under normal conditions (i.e., to remove the low basal level of irreversibly stalled RNAPII), but not during transcriptional stress, such as that encountered during DNA damage in the absence of Rad26. Experiments aimed at elucidating potential differences between the ubiquitylation sites are presently in progress.
A complex relationship between RNAPII ubiquitylation and degradation was underscored by the finding that although K695R mutation led to a dramatic decrease in detectable RNAPII polyubiquitylation, the mutation had little Figure 6 . Ubc5 Orders the CTD-Associated Rsp5 Molecules across RNAPII (A) GST or GST-Ubc5 was incubated with Rsp5, and resin-associated proteins resolved on SDS-PAGE. A Coomassie-stained gel is shown. (B) Gel mobility of an RNAPII elongation complex in the absence or presence of Ubc5, Rsp5, or both. Added factors are indicated above. In lanes 5 and 6 is gel mobility of RNAPII-Rsp5-Ubc5 elongation complexes upon addition of anti-Rsp5 (lane 5) or anti-Ubc5 (lane 6) antibody. In lanes 7-12 is gel mobility of RNAPII elongation complexes that have different lengths of CTD, in the absence or presence of Rsp5 as indicated. To save space, the bottom of the gel (free RNA) was been omitted. (C) Gel mobility of wt and mutant RNAPII elongation complexes in the absence or presence of Ubc5, Rsp5, or both. Migration and content of complexes resulting from factor addition are indicated next to lanes. Figure S5 shows a version of Figure 6B with the identity of the different complexes schematically indicated. effect on UV-induced RNAPII degradation. Although other possibilities cannot be ruled out, this might be explained if proteolysis, rather than ubiquitylation, is rate limiting under the conditions required to detect degradation (i.e., a high dose of UV irradiation, where a generally elevated level of proteasomal activity is needed for cell survival), so that though the rate of RNAPII ubiquitylation is reduced in the absence of K695, this does not significantly affect RNAPII degradation during the first few hours after UV irradiation.
The Locations of the RNAPII Ubiquitylation Sites Placement of the ubiquitylation sites in the RNAPII structure shows that they are very far from each other and from the exit point of the functionally important CTD (Figure 7A) . It also supports the idea that the location of the ubiquitylation sites is functionally relevant.
Changes in the RNAPII protein structure between the transcribing complex and the free enzyme include closure of a clamp over the DNA and RNA and ordering of a series of ''switches'' in the clamp to create a binding site complementary to the DNA-RNA hybrid (Gnatt et al., 2001) . K330 is located in one of these switches (switch 2) ( Figures 7A  and S6A ). The structural ordering of switch 2 may explain why simply incorporating RNAPII into a ternary RNAPII/ DNA/RNA complex in vitro makes it a much better substrate than the free enzyme. Indeed, Ubc5 prefers binding the elongating RNAPII form in vitro ( Figure S7 ). This is of obvious relevance for the situation in cells where, besides the importance of the RNAPII phosphorylation state (Somesh et al., 2005) , the structural conformation of the polymerase might add specificity to the ubiquitylation reaction, so that the elongating form is preferentially targeted. Interestingly, ubiquitin transfer to such a functionally important domain, relatively close to the RNAPII active site, might also be expected to affect transcription ability, or fidelity, as RNAPII arrests. This is presently under investigation.
The other ubiquitylation site, K695, is situated immediately below the Rpb9 subunit in the RNAPII structure ( Figures 7A and S6B) . This opens the possibility that Rpb9, important for transcript elongation and transcription-coupled repair (Hemming et al., 2000; Li and Smerdon, 2002) , also plays a role in RNAPII ubiquitylation. Indeed, we have found that ubiquitylation is perturbed in RNAPII lacking the Rpb9 subunit (B.S. and J.Q.S., unpublished data).
The Mechanism of RNAPII Ubiquitylation
The results reported here make it possible to propose a detailed model for the mechanism of RNAPII ubiquitylation by Ubc5 (E2) and Rsp5 (E3) ( Figure 7B ). This model and the experiments that led to it were guided and also given credence by the RNAPII crystal structures Gnatt et al., 2001; Westover et al., 2004) . Our results indicate that two E2/E3 complexes form on RNAPII, enabling the two distant ubiquitylation events to take place ( Figure 7B, left panel) . In the absence of just one of the RNAPII ubiquitylation sites, correct assembly of these connected complexes is perturbed, and little ubiquitylation takes place, suggesting that a conformational effect is transmitted through the chain of proteinprotein interactions from one site to the other. Alternatively, the effect of site mutation might be due entirely to decreased binding affinity when one site, rather than two, is present. According to this model, the two Rsp5 molecules need to be precisely aligned with the substrate lysines, via the association of Rsp5 with Ubc5 (bound at the target sites) so that ubiquitin can be correctly transferred from E2 to E3 to these target sites. In the absence of K330, the weak binding of Ubc5 at K695 is insufficient to lead to Rsp5 association (and CTD ordering) ( Figure 7B , right panel). Therefore, very little ubiquitylation is possible. In the absence of K695, some association of Rsp5 via K330 bound Ubc5 is observed, but the Ubc5-Rsp5-substrate complex formed is suboptimal, leading to reduced ubiquitylation efficiency ( Figure 7B , bottom panel). Whether Rsp5 forms an actual dimer in which the monomers functionally interact or whether the CTD provides the only connection between the Rsp5 molecules remains to be resolved.
The fact that mutation of either one of the two sites is sufficient to dramatically reduce RNAPII ubiquitylation indicates that binding of Ubc5 to the ubiquitylation sites is crucial for activity. The structural difference between lysine and arginine (the change made in the mutants) is small, though the protonation state of the domains in question might be altered as a result of the change. It is thus possible that the failure to ubiquitylate is due to an increase in the binding dissociation constant upon site mutation. If so, it might be expected that normal ubiquitylation of RNAPII in vitro would be recovered by adding more Ubc5. Indeed, preliminary experiments indicate that addition of a 2-to 4-fold excess of ubiquitylation proteins makes it possible to detect ubiquitylation in mutant RNAPII (data not shown).
Implications for Protein Ubiquitylation Models
It is generally accepted that E3s are responsible for substrate recognition, whereas E2s either hand over ubiquitin to the E3 (HECT E3s) or directly ubiquitylate the substrate after associating with substrate bound E3 (ring E3s) (Pickart, 2001; Ardley and Robinson, 2005) . However, in the case presented here, it is the E2, which directly recognizes the ubiquitylation sites. Indeed, one of the sites, K330, is bound so strongly that it is required for association of RNAPII with immobilized Ubc5 under certain conditions. Interestingly, although sequence-specific protein recognition of a modification site by an E2 has not to our knowledge previously been reported for protein ubiquitylation, the E2 dedicated to protein sumoylation, Ubc9, recognizes a c-K-x-D/E motif (where c is a hydrophobic residue and x is any amino acid) (Bernier-Villamor et al., 2002) . Neither of the RNAPII ubiquitylation sites conforms to this consensus. Moreover, alignment of the sequences surrounding K330 and K695, respectively, shows no (Westover et al., 2004) viewed from above with the DNA (green) and RNA product (magenta), as well as the path of the DNA template (yellow cylinder, arrow showing direction of transcription) indicated. Ubiquitylation sites and the CTD exit point are indicated as colored spheres. Note that in this view the ubiquitylation sites are partly hidden by protein density. In the right panel is a front view of the RNAPII structure. Here, the ubiquitylation site lysines (in red) are indicated with their side chains. An expanded view of K330 and K695 is provided in Figure S6. (B) A model for the mechanism of RNAPII ubiquitylation. As shown in the left panel, with wt RNAPII, Ubc5 can bind the body of the polymerase around the ubiquitylation sites, and two molecules of Rsp5 bind the CTD. These are brought to the sites of ubiquitylation (thereby ordering the CTD across the surface of RNAPII) by the Rsp5-Ubc5 interaction. As shown in the right panel, in the absence of K330, Ubc5 binding to that site is reduced, and the correct placement of (both) CTD bound Rsp5 is hindered. No ubiquitylation takes place. As shown in the lower panel, in the absence of K695, Ubc5 binding to that site is reduced, and although some association at K330 still takes place, a fully functional Ubc5-Rsp5-substrate complex is not formed. Only little ubiquitylation therefore takes place. Red circles indicate ubiquitylation sites. Gray circles indicate mutated ubiquitylation sites. conserved amino acids (except for the lysines), and there is no recognizable degenerate recognition motif or obvious structural similarity between the regions. Thus, although the site specificity of the ubiquitylation system is unmistakeable and observed both in vivo and in vitro, further studies are required to uncover the structural basis for RNAPII substrate-sequence recognition by Ubc5.
A recent model on ubiquitin transfer by HECT ubiquitin ligases (based on structural work on the Rsp5 homolog, WWP1 [Verdecia et al., 2003] ) proposes that transfer of ubiquitin from the active site of the E2 to that of the E3 is followed by a dramatic conformational change in the E3 around a flexible hinge connecting the active site lobe and the E2 binding lobe, allowing the E3 active site to ''swing away'' from the E2 to transfer ubiquitin to the substrate. It is implicit in this model that the E2 is at a considerable distance from the site of modification on the substrate, which does not appear to be the case in the situation presented here. The structural details of ubiquitin transfer by HECT ligases remains an important open question.
The Role of the CTD The function of the CTD of RNAPII has been the subject of immense interest over the last decade. It is clear from numerous studies that the CTD plays a pivotal role in just about all transcription reactions, via its (often phosphorylation-dependent) interactions with distinct proteins (Kobor and Greenblatt, 2002; Meinhart et al., 2005) . In the crystal structure, the absence of electron density owing to the linker and CTD provides evidence of motion or disorder, but even if disordered, the CTD is unlikely to be in a completely extended conformation. Indeed, the linker and CTD regions of four neighboring RNAPII molecules share a space in the crystal that can only accommodate them in a fairly compact conformation ). This does not rule out the possibility that the CTD adopts different conformations and positions depending on the circumstances, but the position of the CTD relative to the body of the polymerase during the different steps of the transcription cycle has so far only been the subject of speculation (Meinhart et al., 2005) . Our data indicate that a full-length CTD (26 repeats), but not a 12-repeat CTD, allow the assembly of an E3 dimer, which is then brought into contact with the sites of ubiquitylation through interaction with the E2. The position of the ubiquitylation sites and the CTD in the crystal structure, the inability of a shortened CTD to support ubiquitylation, and the gel mobility of the E2/E3-associated RNAPII elongation complex, together suggest that the CTD becomes ordered across the body of RNAPII, and outline the direction it follows from its base on one side and across at least 175 Å ngstroms to the other side of the molecule during RNAPII ubiquitylation (Figure 7) . The data presented here thus also provide a rare glimpse into the structural flexibility afforded by the CTD and afford a conceptual framework on which to build structural models for other CTD-dependent molecular processes.
EXPERIMENTAL PROCEDURES

Yeast Strains and Expression Plasmids
Strains for genetic experiments were congenic with W303, and some were described previously (Somesh et al., 2005) . Other strains and bacterial expression plasmids used (source) were RPB1-C6 CTD (Richard Young, Whitehead Institute), YF2277 (Jim Friesen, University of Toronto), GST-Rsp5/GST-Rsp5 C777A (Jon Huibregtse, University of Texas), GST-Ubc5/GST-Ubc5 C85A (Aaron Ciechanover, Technion-Israel Institute of Technology), and GST-CTD (Nick Proudfoot, University of Oxford).
Site-Directed Mutagenesis and Yeast Manipulation
Site-directed mutagenesis was performed on a plasmid containing a fragment of the RPB1 gene using the QuikChange II XL mutagenesis kit (Stratagene, La Jolla, CA). Oligonucleotide sequences are available on request. To generate yeast strains expressing single-, double-, or triple-mutated Rpb1, mutated RPB1 fragments were inserted in place of the wt fragment in RPB1 carried on a TRP1 CEN plasmid. These plasmids were transformed into YF2277 (containing wt RPB1 on a URA3 CEN plasmid [Archambault et al., 1998] ). Cells expressing only mutated Rpb1 (or wt control) from the TRP1 plasmid were selected on 5-fluoroorotic acid (5-FOA)-containing media, evicting the URA3 marker. For similar experiments with dst1 rpb1 and rad26 rpb1 strains, DST1 or RAD26, respectively, was replaced with the HIS3 marker in YF2277. rad26 rpb1 strains were tested for UV sensitivity by irradiation (60 J/m 2 ) in a UV Stratalinker 2400 (Stratagene, La Jolla, CA). Plates were incubated for 3-4 days at 30 C.
For 6-AU sensitivity assays, strains were made URA+ by transformation with pRS316 and grown on synthetic complete medium plates lacking uracil (SCÀuracil), or SCÀuracil plates containing 6-AU (50 mg/ml).
Proteins, In Vitro Ubiquitylation, and Mapping of Ubiquitylation Site of Rpb1 His-tagged ubiquitin, yeast GST-Uba1, GST-Ubc5, GST-Rsp5, RNAPII, and CTD-less RNAPII were obtained/purified as previously described (Somesh et al., 2005) . His-tagged ubiquitin lacking lysines (for monoubiquitylation) was obtained from Boston Biochemical. GST-less Rsp5 was generated by cleaving GST-Rsp5 with PreScission Protease (Amersham Biosciences) in 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM DTT (pH 7.0) for 16 hr at 4 C. Free GST/uncut GST-Rsp5 was removed using glutathione sepharose. GST-CTD was purified as described for purification of other GST-tagged proteins (Somesh et al., 2005) . In vitro ubiquitylation of RNAPII and mapping of ubiquitylation sites was done as described (Somesh et al., 2005) .
Assembly of RNAPII Ternary Complexes and Gel Mobility
Shift Assays RNAPII ternary complexes were assembled from oligonucleotides as described (Somesh et al., 2005) . The RNA oligonucleotide was end labeled using T4 polynucleotide kinase (New England Biolabs). Ternary complexes were resolved by 0.7% agarose gel electrophoresis for 12-14 hr at 4 C, followed by autoradiography.
Immunoprecipitation of Ubiquitylated RNAPII
The effect on ubiquitylation and Rpb1 degradation of 6-AU or UV irradiation in vivo was tested as described (Somesh et al., 2005) .
Binding Experiments
Purified glutathione-s-transferase (GST), GST-Rsp5, or GST-Ubc5 was incubated for 60 min with glutathione sepharose (Pharmacia) in buffer (10% glycerol, 0.5% Triton X-100 in phosphate-buffered saline). Beads were washed and incubated for 2-3 hr with RNAPII (and/or untagged Rsp5) in incubation buffer (50 mM Tris-Cl, pH 7.5, 300 mM KOAc, 0.5% Triton X-100, 10% glycerol) with constant mixing. For experiments in which RNAPII was immobilized via the CTD (to 4H8 beads) ( Figure 3E ), only 200 mM KOAc was used in the incubation buffer). After incubation, beads were washed three times with incubation buffer and boiled in sodium dodecyl sulphate (SDS) sample buffer. Bound proteins were analyzed by SDS-PAGE, followed by Coomassie staining, Ponceau S staining, or western blotting, as indicated. In experiments assessing the binding of Rsp5 and Ubc5 to CTD-less RNAPII, RNAPII was immobilized on 12CA5-protein A resin. Beads were then incubated for 2-3 hr with GST-Rsp5 or GST-Ubc5 as above. Beads were washed as above and bound proteins analyzed by SDS-PAGE, followed by Ponceau S staining and western blotting. For testing binding of serine 5-phosphorylated RNAPII to immobilized GST-Rsp5, RNAPII was phosphorylated by transcription factor II K as described (Somesh et al., 2005) .
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